Navigation Links
Alfacell Receives Going Concern Audit Opinion
Date:10/23/2008

SOMERSET, N.J., Oct. 23 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that its Annual Report on Form 10-K for the fiscal year ended July 31, 2008, filed with the Securities and Exchange Commission on Oct. 14, 2008, included an audit opinion from its independent registered public accounting firm that expressed doubt about the company's ability to continue as a going concern. The company makes this announcement in compliance with NASDAQ Marketplace Rule 4350(b)(1)(B), which requires that a Nasdaq-listed company that receives an audit opinion in which the auditor expresses doubt about the company's ability to continue as a going concern for a reasonable period of time must make a public announcement through the news media disclosing the receipt of such opinion. This announcement and press release do not represent any amendment to the company's 2008 Annual Report on Form 10-K.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to a recently completed Phase IIIb study in malignant mesothelioma, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit http://www.alfacell.com.

Media and Investor Contact:

David Schull or Wendy Lau

Russo Partners

212-845-4271

<
'/>"/>
SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Alfacell to Present at BIO InvestorForum 2007
2. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
3. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
4. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
5. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
6. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
7. Alfacell Announces Retirement of Chief Executive Officer
8. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
9. Alfacell Receives NASDAQ Non-Compliance Notification
10. Alfacell Receives NASDAQ Delisting Letter
11. Alfacell Hires Advisors to Advance Strategic Alternatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 TechConnect World, an event brin...t and product integration in cleantech, nanotech, ...line for technology abstracts and business present...rld, in association with the Nano Science and Tech...and Sustainable Industries Organization (CTSI), wi...
(Date:12/2/2009)...re-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AE...ceutical company focused on endocrine therapy and ...rug Administration (FDA) has granted Fast Track de...itor compound, perifosine (KRX-0401), for the trea...yx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is ...
(Date:12/1/2009)... PDL BioPharma, Inc. (PDL...e for the fourth quarter ended December 31, 2009 o...million for the fourth quarter of 2008. Included i... installment payments of $12.5 million from Alexio...as a one-time $1.8 million payment from Genentech ...
(Date:12/1/2009)... 1 To address the emergence of the...ential, a group of individuals and companies annou...ry Association (SynBIA) in Cambridge, Massachusett...vide a forum for individuals and commercial intere...tunities and its challenges, and advocate for its ...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
... , Molecular Devices Corporation , , ...cribes the use of the SPECTRAmax GEMINI XS from ...LIVE/DEAD Viability/Cytoxicity Assay Kit for ani...alcein AM (cal AM) and ethidium homodimer (EthD-1)...l AM is an electrically neutral, nonfluorescent, e...
...nd Rapid Assay , Uses High Efficiency Fluores...says a broad range of tyrosine kinases , Requir... kit and in bulk packaging , , Introduction... be accelerated using High Efficiency Fluorescence...KXtra HEFP Assay Reagents provides a sensitive a...
...dfield, Martin Boissonneault, Esther Tremblay, Ben... , Recent advances in combinatorial chemi...ented increase in both the number of compounds and...development of automated liquid handling and micro...for increased throughput. Concomitantly, the intro...
Other Biology Technology:LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43) 2LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43) 3LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43) 4LIVE/DEAD Viability/Cytotoxicity Assay for Animal Cells Using the SpectraMax Gemini XS Fluorescence Microplate Reader (MaxLine Application Note #43) 5TKXtra DataFile: Homogenous tyrosine kinase detection using High Efficiency Fluorescence Polarization 2TKXtra DataFile: Homogenous tyrosine kinase detection using High Efficiency Fluorescence Polarization 3Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 2Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 3Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 4Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets. 5
(Date:12/2/2009)...d other foods have done more than raise public awa...e quietly fueling a boom in the market for food te...lations. That,s the topic of the two-part cover st...g News , (C&EN) ACS, weekly newsmagazine. , C&EN...spondent Marc Reisch point out that food safety is...
(Date:12/2/2009)... students from Stevens Institute of Technology was...osted by the International Society for Pharmaceuti...hlights the research conducted by the students and... San Diego, Calif. , The winning poster, titled ...oning Device," was presented by Aaron Rella, a Bio...
(Date:12/2/2009)...nd are more likely to go on to university, reveals...Academy and Sahlgrenska University Hospital. , T... Proceedings of the National Academy of Sciences ...men doing military service who were born between 1...lts of both physical and IQ tests when the men enr...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2Shining a light on disease tracking light emitting bacteria during infection 56496 1Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3Immucor to Present at Upcoming Investor Conferences 56489 1
...ton, DC The National Association of Biology Teach...ssor of biology at the University of Minnesota, wi...ABT annual conference to be held 15-18 October 200...ion Award is cosponsored by the American Institute...Sciences Curriculum Study (BSCS). The award is pr...
...-Scientists from The Forsyth Institute, working wi...es, have discovered a new control over embryonic s...atural bioelectrical mechanism within frog embryon...including increased cell growth, change in cell sh...esearch shows that electrical signals are a powerf...
...the male-dominated societies of their chimpanzee r...igher social status than maleshas a "make-love-not...ntly band together to hunt and kill monkeys, the m...t meat they do eat to forest antelopes, squirrels,...ported in the October 14th issue of Current Biolo...
Other Biology News:Biologists, educators recognize excellence in evolution education 2Biologists, educators recognize excellence in evolution education 3Forsyth scientists trigger cancer-like response from embryonic stem cells 2Despite 'peacenik' reputation, bonobos hunt and eat other primates too 2
HRP Monoclonal-Goat Diluent - 5X Concentrate from BioFX Laboratories, Inc.
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
...153; PCR Cloning Kits are designed to speed up the...oducts, regardless of sequence or type of polymera...including those that are difficult to clone by oth...code for potentially detrimental proteins can be c...
Mounting Medium from BioVision
Biology Products: